ArticleBMC cancer2026
Association of SMAD4 gene polymorphisms with human papillomavirus infection and risk of cervical cancer: a case-control study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the association between SMAD4 gene single nucleotide polymorphisms (SNPs) and the risk of human papillomavirus (HPV) infection and cervical cancer.
methodsA case-control study was conducted, enrolling 342 cervical cancer patients as the case group and 342 healthy individuals from concurrent physical examinations as the control group. Genotyping of SMAD4 SNP loci rs34468925 and rs8084630 was performed using the imLDR SNP genotyping technique. HPV detection in the case group was performed via PCR-reverse dot hybridization. Statistical analysis and the online SHEsis software were employed to comprehensively evaluate the association between the rs34468925 and rs8084630 SNP loci, their haplotypes, and the risk of HPV infection and cervical cancer.
resultsNo significant association was observed between the genotypes, alleles, genetic models (dominant and recessive), or haplotypes of the SMAD4 gene SNPs rs34468925 and rs8084630 and HPV infection risk in either group (P > 0.05). rs8084630 showed no association with cervical cancer risk (P > 0.05). However, the TT genotype, T allele, and recessive genetic model of rs34468925 were significantly associated with a reduced risk of cervical cancer (P < 0.05). Additionally, the rs34468925 CT genotype may be associated with clinical pathological characteristics (tumor classification, distant metastasis) in cervical cancer patients (P < 0.05).
conclusionThe SMAD4 rs34468925 polymorphism shows no significant association with HPV infection but is inversely associated with cervical cancer risk and certain clinicopathological characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.